In previous studies, we demonstrated that the pan-PPAR agonist 1d improves insulin resistance in T2DM mice by inhibiting PPARγ Ser273 phosphorylation in white adipose tissue and modulating the expression of genes such as adiponectin, without inducing weight gain or fluid retention. Here, ADIPOQ is linked to type 2 diabetes mellitus.